Avenue Therapeutics
New York
About Avenue Therapeutics
Avenue Therapeutics is a New York-based, specialty pharmaceutical company founded in 2015. The company is a majority-controlled subsidiary of Fortress Biotech, Inc., a biopharmaceutical company focused on acquiring, developing, and commercializing novel pharmaceutical and biotechnology products.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $19.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2023)
- Ticker: nasdaq:ATXI
- Website: avenuetx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/avenue-therapeutics-174822 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.